Clinical trial Recruiting at 2 sites Interventional Ages 65 and up

Early Detection and Early Treatment in Heart Failure

Official title: Early Detection and IntervenTion in Heart Failure

Run by University Hospital, Basel, Switzerland · NCT07731490 · Data updated 2026-11-12

A bundled approach tests whether increasing awareness and using a simple NT-proBNP blood test can help detect heart failure earlier and reduce hospitalizations for people 65 and older who are having certain heart procedures or high-risk situations.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment18000 (estimated)
SponsorUniversity Hospital, Basel, Switzerland
Academic / other
Locations21 sites (Vienna and 20 other locations)
StatusRecruiting
StartedDecember 3, 2025
Main results expectedApril 2028
Study endsApril 2030
Registry record updatedJuly 28, 2026
Trial IDNCT07731490 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 65 or older undergoing selected cardiac procedures or presenting with tachyarrhythmias and no prior diagnosed heart failure, who meet local eligibility criteria.

Probably not a fit

Patients with established heart failure, renal impairment (eGFR <30), certain cancers, or non-residency in the country of the recruiting site may not benefit from this strategy.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study tests a combined strategy to detect heart failure earlier and start treatment sooner in adults aged 65 and older undergoing specific cardiac procedures or presenting to the emergency department with tachyarrhythmias. The strategy includes raising awareness among patients and clinicians, implementing NT-proBNP testing for early diagnosis, and initiating timely treatment to improve outcomes. The trial assesses whether this approach can lower hospitalization rates related to heart failure and slow disease progression. Enrollment is limited to participants meeting specific eligibility criteria and excludes those with established heart failure, certain comorbidities, or non-residence in the recruiting country. Primary sponsor is University Hospital Basel, with international sites in Vienna, Sofia, and Freiburg.

Why it matters

Potential benefit: If successful, patients may experience earlier diagnosis and treatment of heart failure, potentially reducing hospitalizations and slowing disease progression.

How similar studies have gone: Prior studies indicate substantial undetected heart failure in high-risk populations, suggesting potential benefit from proactive screening and early treatment strategies, though this exact bundled approach is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* General consent (GC) has not been rejected.
* Age ≥ 65 years.
* Elective percutaneous coronary intervention\* (PCI), pulmonary vein isolation\* (PVI), pacemaker implantation\* (PM, no cardiac resynchronisation), transcatheter aortic valve intervention\* (TAVI), major non-cardiac surgery\* or presenting with tachyarrhythmia to the emergency department (ED) (without a diagnosis of HF within 24h).

  * Exclusion criteria are assessed on day 1 after the procedure

Exclusion Criteria:

* Systolic blood pressure ≤ 95 mmHg
* Estimated glomerular filtration rate (GFR) \<30 mL/min/1.73 m2.
* Dementia documented in the medical history.
* Metastatic cancer in the medical history.
* Previously enrolled in this study.
* Known HF.
* Known allergies, hypersensitivity, or intolerance to SGLT2 Inhibitors / Loop Diuretics / MRA or is excipients.
* Non-resident in the country of the recruiting site
* Incapacity of the patient to make judgements
* Patients not hospitalized overnight
* Patients requiring intensive care unit (ICU) or intermediate care (IMC) stay beyond 11:00 a.m. on the first postoperative day or any post-interventional stroke unit stay until 8:00 a.m. on the first postoperative day.
* Patients died prior to postinterventional day 1 (8:00 a.m.)
* Severe aortic or mitral stenosis

Where it's running

  • Konkuk University Medical Center
    Seoul, South Korea
    Recruiting
  • University Hospital Basel
    Basel, Basel, Switzerland
    Recruiting
  • Universitätsklinik für Innere Medizin II
    Vienna, Austria
    Not yet recruiting
  • Queen Giovanna University Hospital
    Sofia, Bulgaria
    Not yet recruiting
  • University Hospital Freiburg-Bad Krozingen
    Freiburg im Breisgau, Germany
    Not yet recruiting
  • Universitätsklinikum der Ruhr-Universität Bochum
    Herne, Germany
    Not yet recruiting
Show 15 more locations
  • Herzzentrum Leipzig, Klinik für Innere Medizin/Kardiologie
    Leipzig, Germany
    Not yet recruiting
  • University Hospital Pisa
    Pisa, Italy
    Not yet recruiting
  • Erasmus MC Rotterdam
    Rotterdam, Netherlands
    Not yet recruiting
  • University Hospital Ramón y Cajal Madrid
    Madrid, Spain
    Not yet recruiting
  • University Hospital Lausanne
    Lausanne, Lausanne, Switzerland
    Not yet recruiting
  • KSA Kantonsspital Aarau
    Aarau, Switzerland
    Not yet recruiting
  • Cantonal Hospital Baden
    Baden, Switzerland
    Not yet recruiting
  • St. Claraspital AG
    Basel, Switzerland
    Not yet recruiting
  • University Hospital Genève
    Geneva, Switzerland
    Not yet recruiting
  • Kantonsspital Luzern
    Lucerne, Switzerland
    Not yet recruiting
  • Hospital Istituto Cardiocentro Ticino
    Lugano, Switzerland
    Not yet recruiting
  • Kantonsspital St. Gallen
    Sankt Gallen, Switzerland
    Not yet recruiting
  • Stadtspital Zürich
    Zurich, Switzerland
    Not yet recruiting
  • University Hospital Zurich
    Zurich, Switzerland
    Not yet recruiting
  • Royal Infirmary Edinburgh
    Edinburgh, United Kingdom
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.